Evaluation of Factors Predicting Recurrence in Oral Squamous Cell Carcinoma.

IF 0.4 Q4 SURGERY
Ridhi Gupta, Vipin Arora, Pragya Shukla, Sonal Sharma
{"title":"Evaluation of Factors Predicting Recurrence in Oral Squamous Cell Carcinoma.","authors":"Ridhi Gupta, Vipin Arora, Pragya Shukla, Sonal Sharma","doi":"10.1007/s12070-025-05637-8","DOIUrl":null,"url":null,"abstract":"<p><p>Oral cancer is the most common type of cancer in Indian males. Recurrent disease occurs in 17-40% of patients after primary treatment. Out of these around 20-30% recur at primary site and 10-15% at loco-regional nodal area with greater than 90% of recurrences occurring in first 2 years Survival rate is less even after advancement in management strategies. Most of the patients present at an advanced stage of the disease when the lymph node metastasis has already occurred which determines the outcome and leads to poor prognosis. Even if meticulous treatment, the risk of regional recurrence cannot be eliminated. We undertook to study and compare the factors responsible for locoregional control rate, distant control rate, disease free survival rate, recurrence free survival time and overall survival time. All patients enrolled in Department of Otorhinolaryngology, GTBH and DSCI, Delhi with surgery as integral part of treatment and upto 2 year of follow up were included and studied. Bony invasion (<i>p</i> = 0.001) and positive margins (<i>p</i> = 0.006) were found to be significant predictor of recurrence. LVI and Lymph node staging decreased RFS time (<i>p</i> < 0.05). LVI and ECE was associated decreased OS. 2 year overall survival rate with and without recurrence were 36% and 68% respectively. Mortality rates after recurrence was found to be 62%, RFS was 51%. Histopathologically, advanced diseases are associated with high recurrence rate, Bone involvement, margin status, LVI, ECE, advanced N-Stage being important predictors. Recurrence is always associated with poor outcome.</p>","PeriodicalId":49190,"journal":{"name":"Indian Journal of Otolaryngology and Head and Neck Surgery","volume":"77 8","pages":"3084-3090"},"PeriodicalIF":0.4000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12297042/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Otolaryngology and Head and Neck Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12070-025-05637-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/12 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Oral cancer is the most common type of cancer in Indian males. Recurrent disease occurs in 17-40% of patients after primary treatment. Out of these around 20-30% recur at primary site and 10-15% at loco-regional nodal area with greater than 90% of recurrences occurring in first 2 years Survival rate is less even after advancement in management strategies. Most of the patients present at an advanced stage of the disease when the lymph node metastasis has already occurred which determines the outcome and leads to poor prognosis. Even if meticulous treatment, the risk of regional recurrence cannot be eliminated. We undertook to study and compare the factors responsible for locoregional control rate, distant control rate, disease free survival rate, recurrence free survival time and overall survival time. All patients enrolled in Department of Otorhinolaryngology, GTBH and DSCI, Delhi with surgery as integral part of treatment and upto 2 year of follow up were included and studied. Bony invasion (p = 0.001) and positive margins (p = 0.006) were found to be significant predictor of recurrence. LVI and Lymph node staging decreased RFS time (p < 0.05). LVI and ECE was associated decreased OS. 2 year overall survival rate with and without recurrence were 36% and 68% respectively. Mortality rates after recurrence was found to be 62%, RFS was 51%. Histopathologically, advanced diseases are associated with high recurrence rate, Bone involvement, margin status, LVI, ECE, advanced N-Stage being important predictors. Recurrence is always associated with poor outcome.

口腔鳞状细胞癌复发预测因素的评价。
口腔癌是印度男性中最常见的癌症类型。17-40%的患者在初次治疗后复发。其中约20-30%在原发部位复发,10-15%在局部-区域淋巴结区复发,90%以上的复发发生在头2年,即使在治疗策略的改进后生存率也较低。大多数患者出现在疾病的晚期,此时已经发生淋巴结转移,这决定了预后,导致预后不良。即使精心治疗,也不能消除局部复发的风险。我们着手研究和比较影响局部控制率、远处控制率、无病生存率、无复发生存时间和总生存时间的因素。纳入并研究了所有在德里耳鼻喉科GTBH和DSCI纳入的患者,手术是治疗的组成部分,随访时间长达2年。骨浸润(p = 0.001)和阳性切缘(p = 0.006)是复发的重要预测因子。LVI和淋巴结分期降低了RFS时间(p
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
226
审稿时长
6-12 weeks
期刊介绍: Indian Journal of Otolaryngology and Head & Neck Surgery was founded as Indian Journal of Otolaryngology in 1949 as a scientific Journal published by the Association of Otolaryngologists of India and was later rechristened as IJOHNS to incorporate the changes and progress. IJOHNS, undoubtedly one of the oldest Journals in India, is the official publication of the Association of Otolaryngologists of India and is about to publish it is 67th Volume in 2015. The Journal published quarterly accepts articles in general Oto-Rhino-Laryngology and various subspecialities such as Otology, Rhinology, Laryngology and Phonosurgery, Neurotology, Head and Neck Surgery etc. The Journal acts as a window to showcase and project the clinical and research work done by Otolaryngologists community in India and around the world. It is a continued source of useful clinical information with peer review by eminent Otolaryngologists of repute in their respective fields. The Journal accepts articles pertaining to clinical reports, Clinical studies, Research articles in basic and applied Otolaryngology, short Communications, Clinical records reporting unusual presentations or lesions and new surgical techniques. The journal acts as a catalyst and mirrors the Indian Otolaryngologist’s active interests and pursuits. The Journal also invites articles from senior and experienced authors on interesting topics in Otolaryngology and allied sciences from all over the world. The print version is distributed free to about 4000 members of Association of Otolaryngologists of India and the e-Journal shortly going to make its appearance on the Springer Board can be accessed by all the members. Association of Otolaryngologists of India and M/s Springer India group have come together to co-publish IJOHNS from January 2007 and this bondage is going to provide an impetus to the Journal in terms of international presence and global exposure.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信